Document is current
Any future updates will be listed below
-
Authors
Trasanidou, Despoina
Potocnik, Ana
Barendse, Patrick https://orcid.org/0000-0002-6332-354X
Mohanraju, Prarthana
Bouzetos, Evgenios https://orcid.org/0000-0001-5111-4030
Karpouzis, Efthymios
Desmet, Amber
van Kranenburg, Richard
van der Oost, John https://orcid.org/0000-0001-5024-1871
Staals, Raymond H. J. https://orcid.org/0000-0002-5741-9457
Mougiakos, Ioannis https://orcid.org/0000-0001-8853-8208
-
Funding
Funding for this research was provided by:
Dutch Research Council
Alexander S. Onassis Public Benefit Foundation (FZM 083-2/2018-2019)
Dutch Research Council, European Research Council
- License Information
-
More Information
Article History
Received: 25 May 2023
Accepted: 4 October 2023
First Online: 13 October 2023
Competing interests
: The authors declare the following competing interests: J.v.d.O. is cofounder of NTrans Technologies, and a member of the Scientific Advisory Board of NTrans Technologies and Hudson River Biotechnology. J.v.d.O. and R.H.J.S. are members of the Scientific Advisory Board of Scope Biosciences. R.v.K. and I.M. are employed by the commercial companies Corbion (Gorinchem, The Netherlands) and SNIPR Biome (Copenhagen, Denmark), respectively. D.T., J.v.d.O., R.H.J.S., and I.M. are inventors of CRISPR-Cas-related patents/patent applications. All other authors declare no competing interests.
